Armata Pharmaceuticals, Inc. — SC 13D/A Filings
31 SC 13D/A filings on record
This page lists all SC 13D/A filings submitted to the SEC by Armata Pharmaceuticals, Inc. (ARMP), sorted by most recent first. Each row links to the full filing on EdgarLookup. Armata Pharmaceuticals, Inc. has filed 31 SC 13D/A documents with the SEC since 2003. To view all SEC filings by Armata Pharmaceuticals, Inc., see the full filings list.
All
10-12G
10-12G/A
10-K
10-K/A
10-K405
10-K405/A
10-Q
10-Q/A
15-12G
15-12G/A
25
3
3/A
4
424B2
424B3
424B4
424B5
5
8-A12B
8-A12G
8-A12G/A
8-K
8-K/A
ARS
CERTNYS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DEFM14A
EFFECT
FWP
NT 10-K
NT 10-Q
POS AM
POS EX
PRE 14A
PREM14A
PRER14A
REGDEX
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13E3
SC 13E3/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13D/A | SC 13D/A | 0001140361-24-046918 | Nov 14, 2024 | — |
| SC 13D/A | SC 13D/A | 0001140361-24-011136 | Mar 4, 2024 | — |
| SC 13D/A | SC 13D/A | 0001104659-23-079825 | Jul 11, 2023 | — |
| SC 13D/A | SC 13D/A | 0001104659-23-002797 | Jan 10, 2023 | — |
| SC 13D/A | SCHEDULE 13D/A, AMENDMENT #7 | 0000899140-22-000437 | Apr 1, 2022 | — |
| SC 13D/A | SCHEDULE 13D/A (AMENDMENT NO. 6) | 0000899140-22-000224 | Feb 11, 2022 | — |
| SC 13D/A | SCHEDULE 13D/A (AMENDMENT NO. 5) | 0000899140-21-000699 | Nov 1, 2021 | — |
| SC 13D/A | SCHEDULE 13D (AMENDMENT NO. 4) | 0000899140-21-000424 | Apr 5, 2021 | — |
| SC 13D/A | SCHEDULE 13D/A, AMENDMENT #3 | 0000899140-21-000374 | Mar 17, 2021 | — |
| SC 13D/A | SCHEDULE 13D/A, AMENDMENT #2 | 0000899140-21-000094 | Jan 27, 2021 | — |
| SC 13D/A | SCHEDULE 13D/A, #1 | 0000899140-20-000223 | Mar 31, 2020 | — |
| SC 13D/A | RANDAL J KIRK SC 13D/A NO 3 12-30-2016 (AMPLIPHI BIOSCIENCES CORP) | 0001140361-16-091205 | Dec 30, 2016 | — |
| SC 13D/A | RANDAL J KIRK SC 13D A NO 2 11-12-2016 (AMPLIPHI BIOSCIENCES CORP) | 0001140361-16-086986 | Nov 16, 2016 | — |
| SC 13D/A | RANDAL J. KIRK SC 13D A NO. 1 4-15-2016 (AMPLIPHI BIOSCIENCES CORPORATION) | 0001140361-16-061276 | Apr 15, 2016 | — |
| SC 13D/A | — | 0001044321-09-000211 | Oct 9, 2009 | — |
| SC 13D/A | — | 0001044321-07-000208 | Jul 11, 2007 | — |
| SC 13D/A | AMENDMENT NO. 3 | 0000950162-05-000023 | Jan 6, 2005 | — |
| SC 13D/A | AMENDMENT NO. 3 | 0000950162-05-000024 | Jan 6, 2005 | — |
| SC 13D/A | AMENDMENT NO. 2 | 0000950162-04-000471 | Apr 6, 2004 | — |
| SC 13D/A | AMENDMENT NO. 2 | 0000950162-04-000472 | Apr 6, 2004 | — |
| SC 13D/A | AMENDMENT NO. 1 | 0000950162-03-001473 | Nov 6, 2003 | — |
| SC 13D/A | AMENDMENT NO. 1 | 0000950162-03-001472 | Nov 5, 2003 | — |
| SC 13D/A | — | 0000898286-03-000042 | May 1, 2003 | — |
| SC 13D/A | SCHEDULE 13D/A #5 | 0000927016-03-001900 | Apr 18, 2003 | — |
| SC 13D/A | — | 0000898286-03-000037 | Apr 7, 2003 | — |
| SC 13D/A | — | 0000898286-03-000011 | Feb 7, 2003 | — |
| SC 13D/A | — | 0000898286-03-000012 | Feb 7, 2003 | — |
| SC 13D/A | SCHEDULE 13D/A #4 | 0000927016-02-005817 | Dec 6, 2002 | — |
| SC 13D/A | 13D/A | 0000912057-01-512495 | May 3, 2001 | — |
| SC 13D/A | — | 0000904454-98-000103 | May 7, 1998 | — |
| SC 13D/A | AMENDMENT NO. 1 TO SCHEDULE 13D | 0000950123-96-003632 | Jul 16, 1996 | — |